Cargando…

Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)

Age-related macular degeneration (AMD) is responsible for the majority of visual impairment in the Western world. The role of cholesterol-lowering medications, HMG Co-A reductase inhibitors or statins, in reducing the risk of AMD or of delaying its progression has not been fully investigated. A 3-ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guymer, Robyn H, Dimitrov, Peter N, Varsamidis, Mary, Lim, Lyndell L, Baird, Paul N, Vingrys, Algis J, Robman, Luba
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682391/ https://www.ncbi.nlm.nih.gov/pubmed/18982929

Ejemplares similares

Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2013)

Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration
por: Prea, Selwyn, et al.
Publicado: (2023)

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
por: Würtz, Peter, et al.
Publicado: (2016)

Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor
por: Bose, Sucharita, et al.
Publicado: (2023)

The Statin Target HMG-Coenzyme a Reductase (Hmgcr) Regulates Sleep Homeostasis in Drosophila
por: Alsehli, Ahmed M., et al.
Publicado: (2022)

HMG CoA reductase inhibitors (statins) to treat Epstein–Barr virus-driven lymphoma
por: Cohen, J I
Publicado: (2005)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2015)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2014)

Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins
por: Salar, Tooba, et al.
Publicado: (2023)

Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
por: Jiang, Shi-You, et al.
Publicado: (2018)

Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study
por: McCarty, Catherine A, et al.
Publicado: (2008)

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers
por: Meisel, Peter, et al.
Publicado: (2011)

Benefit–risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment
por: Wanishayakorn, Tanatape, et al.
Publicado: (2016)

Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
por: Markowska, Anna, et al.
Publicado: (2020)

The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase
por: Maciejak, Agata, et al.
Publicado: (2013)

Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report
por: Upreti, Sunita, et al.
Publicado: (2019)

HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ
por: Miyajima, Chiharu, et al.
Publicado: (2022)

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival
por: Younas, Nizar, et al.
Publicado: (2010)

AB126. Impact of HMG-CoA reductase inhibitor (statin) use on serum PSA and prostate volume in BPH patients
por: Park, Heung Jae
Publicado: (2014)

Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells
por: Chiang, Kuang-Hsing, et al.
Publicado: (2015)

Model Lipid Raft Membranes for Embedding Integral Membrane Proteins: Reconstitution of HMG-CoA Reductase and Its Inhibition by Statins
por: Zaborowska, Michalina, et al.
Publicado: (2022)

NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements
por: Lachenmeier, Dirk W, et al.
Publicado: (2012)

Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics
por: Ishikawa, Takuro, et al.
Publicado: (2018)

Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome
por: Sarsenbayeva, Assel, et al.
Publicado: (2021)

Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG‐CoA reductase inhibition
por: Lindsay, Chris, et al.
Publicado: (2022)

The Question of a Role for Statins in Age-Related Macular Degeneration
por: Roizenblatt, Marina, et al.
Publicado: (2018)

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020)

Statins and the progression of age-related macular degeneration in the United States
por: Ludwig, Cassie A., et al.
Publicado: (2021)

Risk Factors for Age-Related Maculopathy
por: Connell, Paul P., et al.
Publicado: (2009)

Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use
por: Pulipati, Priyanjali, et al.
Publicado: (2022)

Age-Related Hypercholesterolemia and HMG-CoA Reductase Dysregulation: Sex Does Matter (A Gender Perspective)
por: Trapani, Laura, et al.
Publicado: (2010)

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy
por: Monson, John P, et al.
Publicado: (2007)

The association between statin use and risk of age-related macular degeneration
por: Ma, Le, et al.
Publicado: (2015)

Sex and APOE genotype differences related to statin use in the aging population
por: Dagliati, Arianna, et al.
Publicado: (2021)

Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) study
por: Scott, Colin, et al.
Publicado: (2022)

Fundus Autofluorescence Changes in Age-related Maculopathy
por: Bingöl Kızıltunç, Pınar, et al.
Publicado: (2018)

HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection
por: Vamvakopoulos, Joannis E, et al.
Publicado: (2003)

The Cognitive Effects of Statins are Modified by Age
por: Alsehli, Ahmed M., et al.
Publicado: (2020)

IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach
por: Silva, Mariana, et al.
Publicado: (2021)

Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes
por: Hackett, Geoffrey, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8tub7gjk2isqjc35bvkvrrjg1i